垂体后叶素辅助治疗肺结核大咯血的疗效观察
详细信息    查看全文 | 推荐本文 |
  • 英文篇名:Efficacy of Pituitrin in the Treatment of Massive Hemoptysis of Pulmonary Tuberculosis
  • 作者:杨高 ; 杨高
  • 英文作者:Yang Gaoxiong;Infection Department,Lianjiang Municipal People's Hospital;
  • 关键词:肺结核 ; 垂体后叶素 ; 咯血
  • 英文关键词:tuberculosis;;pituitrin;;hemoptysis
  • 中文刊名:SLYY
  • 英文刊名:Journal of Mathematical Medicine
  • 机构:廉江市人民医院感染内科;
  • 出版日期:2019-03-15
  • 出版单位:数理医药学杂志
  • 年:2019
  • 期:v.32
  • 语种:中文;
  • 页:SLYY201903056
  • 页数:2
  • CN:03
  • ISSN:42-1303/R
  • 分类号:122-123
摘要
目的:分析讨论对肺结核大咯血患者使用垂体后叶素辅助治疗的具体效果和实际价值。方法:选取某院2016年1月~2017年12月肺结核大咯血患者60例,根据入院先后将其均分为对照组和观察组,每组30例。对照组进行常规止血治疗,观察组在上述治疗基础下进行垂体后叶素治疗,比较两组患者止血时间、住院时间和总有效率。结果:观察组止血时间和住院时间明显低于对照组,P<0.05;观察组和对照组总有效率依次为96.67%和76.66%,观察组明显高于对照组,P<0.05。结论:垂体后叶素能让肺结核患者短时间内停止咯血,整体治疗效果良好。
        Objective: To analyze and discuss the specific effect and practical value of adjuvant therapy with Pituitrin in patients with massive hemoptysis of pulmonary tuberculosis. Methods: 60 cases of massive hemoptysis of pulmonary tuberculosis were selected in a hospital from January 2016 to December 2017. According to the hospitalization successively,they were divided into control group and observation group,30 cases in each group. The control group treated with routine hemostatic therapy, the observation group treated with pituitrin on the basis of the above treatment. The hemostasis time,length of stay and total effective rate of the two groups were compared. Results: The hemostasis time and hospitalization time in the observation group were significantly lower than those in the control group,P<0.05. The total effective rates of the observation group and the control group were 96.67% and 76.66% respectively,and the observation group was significantly higher than that of the control group,P<0.05. Conclusion: Pituitrin can make pulmonary tuberculosis patients stop hemoptysis in a short time,and the overall treatment effect is good.
引文
1 曾安津,董霞.硝普钠联合垂体后叶素治疗肺结核大咯血的疗效观察.临床肺科杂志,2013,18(1):106~107.
    2 干小红,龙霞.垂体后叶素联合酚妥拉明治疗肺结核咯血的疗效及安全性的系统评价.中国医院药学杂志,2016,36(5):386~391.
    3 李延玲.脑垂体后叶素配伍酚妥拉明治疗40例肺结核咯血患者临床疗效观察.航空航天医学杂志,2014,25(5):705~706.
    4 冯修国.垂体后叶素治疗肺结核咯血的临床治疗效果及其可行性分析.中西医结合心血管病电子杂志,2014,2(2):8.
    5 刘梦林.垂体后叶素不同给药方法治疗肺结核咯血患者的效果及总结护理要点.数理医药学杂志,2017,30(9):1392~1393.
    6 袁春雨.肺结核咳血患者采用立止血和垂体后叶素治疗对其不良反应的影响.临床医药文献电子杂志,2016,3(42):8425.